The effect of dosing with omeprazole on the accuracy of the 13C-urea breath test in Helicobacter pylori-infected subjects

Aliment Pharmacol Ther. 1999 Oct;13(10):1287-93. doi: 10.1046/j.1365-2036.1999.00601.x.

Abstract

Background: The 13C-urea breath test (13C-UBT) is an accurate means of Helicobacter pylori diagnosis. However, proton pump inhibitors may suppress H. pylori and cause false negative results.

Aim: To study the kinetics of H. pylori suppression by omeprazole during and after short-term use.

Methods: Volunteers underwent a baseline 13C-UBT (13C-urea 100 mg). H. pylori-positive subjects took omeprazole 20 mg daily for 14 days. Those who remained 13C-UBT positive (delta13CO2 >/= 5) continued omeprazole for a further 14 days. 13C-UBTs were performed weekly on omeprazole and then every second day after it was stopped. False negatives occurred when delta13CO2 fell to < 5.

Results: In 25 H. pylori-positive subjects (mean age 43.9 +/- 2.4 years; 21 females, 4 males) the mean baseline delta13CO2 was 28.1 +/- 3.4. False negative breath tests occurred in three subjects after 7 days of omeprazole and in a further four subjects after 14 days. A further six subjects developed negative tests between Days 14 and 28. Following cessation of omeprazole, the 13C-UBT became positive again in 12/13 subjects within 4 days and in all within 6 days, with a mean recovery to 99.9 +/- 18.6% of baseline delta13CO2.

Conclusions: False negative 13C-UBTs are common during treatment with omeprazole and occur after as little as 7 days. Return to positive test results is rapid after cessation of omeprazole. These findings are relevant to the timing of testing in clinical practice.

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Anti-Ulcer Agents / administration & dosage
  • Anti-Ulcer Agents / adverse effects*
  • Anti-Ulcer Agents / pharmacokinetics
  • Breath Tests / methods
  • Carbon Radioisotopes
  • False Negative Reactions
  • Female
  • Helicobacter Infections / diagnosis*
  • Helicobacter Infections / drug therapy
  • Helicobacter pylori* / drug effects
  • Humans
  • Male
  • Omeprazole / administration & dosage
  • Omeprazole / adverse effects*
  • Omeprazole / pharmacokinetics
  • Reproducibility of Results
  • Sensitivity and Specificity
  • Urea*

Substances

  • Anti-Ulcer Agents
  • Carbon Radioisotopes
  • Urea
  • Omeprazole